Does SECUKINUMAB Cause Hypersensitivity vasculitis? 41 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Hypersensitivity vasculitis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
41
Reports of Hypersensitivity vasculitis with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Hypersensitivity vasculitis From SECUKINUMAB?
Of the 41 reports, 10 (24.4%) required hospitalization.
Is Hypersensitivity vasculitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Hypersensitivity vasculitis?
ADALIMUMAB (147)
INFLIXIMAB (97)
METHOTREXATE (89)
ETANERCEPT (81)
RITUXIMAB (69)
RIVAROXABAN (67)
AZATHIOPRINE (66)
FUROSEMIDE (63)
PREDNISONE (63)
AMLODIPINE (54)
Which SECUKINUMAB Alternatives Have Lower Hypersensitivity vasculitis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG